Pharmacokinetics of budesonide and its major ester metabolite after inhalation and intravenous administration of budesonide in the rat

Drug Metabolism and Disposition

Volumn 29, Issue 5, 2001, Pages 769-776

  Jendbro, Magnus ^a   Johansson, Carl Johan ^a   Strandberg, Per ^a   Falk Nilsson, Hanna ^a   Edsbäcker, Staffan ^a,b  

^a ASTRAZENECA R AND D   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

BUDESONIDE; BUDESONIDE OLEATE; DRUG METABOLITE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARTMENT MODEL; DRUG ACCUMULATION; DRUG HALF LIFE; ESTERIFICATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRACHEA;

ADMINISTRATION, INHALATION; ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS; BUDESONIDE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; ESTERS; GLUCOCORTICOIDS; INJECTIONS, INTRAVENOUS; MALE; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 0035042689     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Noncompartmental determination of the steady state volume of distribution
2. Physiologic modeling of cyclosporin kinetics in rat and man
3. Budesonide: An updated review of its pharmacological properties, and therapeutic efficacy in asthma and rhinitis
4. Once-daily inhaled corticosteroids in mild to moderate asthma: Improving acceptance of treatment
5. Oral budesonide is as effective as oral prednisolone in active Crohn's disease (The Global Budesonide Study Group)
6. Physiological parameters in laboratory animals and humans
7. Pharmacological factors that influence the choice of inhaled corticosteroids
8. A dose-response study comparing suppression of plasma cortisol induced by fluticasone propionate from Diskhaler and budesonide from Turbuhaler
9. Biological esterification of steroids
10. Safety of inhaled and intranasal corticosteroids: Lessons for the new millenium
11. Prolonged airway activity and improved selectivity of budesonide possibly due to esterification
12. Reversible fatty acid conjugation of budesonide: Novel mechanism for prolonged retention of topically applied steroid in airway tissue
13. A novel dry powder aerosol delivery system for real time measurement of the inhaled dose to large animals
14. Nasal retention of budesonide and fluticasone in man: Formation of airway mucosal budesonide-esters in vivo
15. Intracellular cholesterol trafficking
16. Nano-thin coatings for improved lung targeting of glucocorticoid dry powders. In vitro and in vivo characteristics
17. Formation of fatty acid conjugates of budesonide in human lung tissue in vivo
18. Reversible formation of fatty acid esters of budesonide, an antiasthma glucocorticoid, in human lung and liver microsomes
19. A comparison of the efficacy and patient acceptability of once daily budesonide via Turbohaler and twice daily fluticasone propionate via disc-inhaler at an equal daily dose of 400/μg in adult asthmatics
20. Pharmacologic importance of the reversible fatty acid conjugation of budesonide studied in a rat cell line in vitro
21. The prolonged activity of a budesonide pulse depends on its reversible intracellular esterification - Studied in vitro